After Covid-19 Vaccines, What Else Can mRNA Tech Do? - a podcast by The Wall Street Journal

The Covid-19 vaccines from Pfizer and Moderna were the first products using mRNA tech to get approved for use. Now scientists and researchers are looking at other uses for that tech, such as more effective flu vaccines or creating the first effective HIV vaccine. Health reporter Jared S. Hopkins joins host Zoe Thomas to discuss where this health tech could be headed next.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Further episodes of WSJ Tech News Briefing

Further podcasts by The Wall Street Journal

Website of The Wall Street Journal